CPT code 21012 represents the surgical excision of a soft tissue tumor on the face or scalp, typically performed to remove a lump or bump and obtain tissue for pathologic analysis. This procedural code captures episodes where a provider excises a usually benign lesion to exclude malignancy, a common ambulatory surgical intervention with implications for coding, billing, and post-procedure pathology processing.

Key payers included in the national analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for use of CPT code 21012, an overview of expected sites of service, and the operational implications for billing departments and revenue cycle teams. The publication summarizes typical payer considerations, common modifier usage (listed separately in technical sections), and how the code fits into outpatient surgical workflows.

This report is intended to inform clinicians, coders, and policy analysts about the clinical purpose of CPT code 21012, where it is commonly reported, and what clinicians and billing professionals should account for when documenting and submitting claims. Data not provided in the input—such as detailed payer-specific reimbursement rates, associated ICD-10 codes, and taxonomy mappings—is identified as unavailable in the technical appendices.